DR. OFER LEVY, MD, PHD
Medical Practice at Longwood Ave, Boston, MA
License number
Massachusetts 216782
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
300 Longwood Ave, Boston, MA 02115
Phone
(617) 919-2900
(617) 730-0255 (Fax)
(617) 730-0255 (Fax)
Organization information
See more information about OFER LEVY at bizstanding.comOfer Levy MD,PHD
300 Longwood Ave, Boston, MA 02115
Industry:
Pediatrician
Phone:
(617) 355-7246 (Phone)
Ofer A. Levy
Children's Hospital Boston - Ofer Levy MD
300 Longwood Ave #FEGAN10, Boston, MA 02115
Categories:
Infectious Disease Physicians & Surgeons
Phone:
(617) 919-2900 (Phone)
Professional information
Principal Investigator At Children's Hospital Boston
Location:
Greater Boston Area
Industry:
Biotechnology
Dr. Ofer Levy, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
Boston Childrens Hosp Infct Dis
300 Longwood Ave, Boston 02115
(617) 919-2900 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
Boston Childrens Hosp Infct Dis
300 Longwood Ave, Boston 02115
(617) 919-2900 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Certifications:
Pediatric Infectious Disease Medicine, 2011, Pediatrics, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York Univ Sch Of Med
Graduated: 1992
Childrens Hospital
New York Univ Sch Of Med
Graduated: 1992
Childrens Hospital
Principal Investgator At Children's Hospital Boston
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Ofer A Levy, Boston MA
Specialties:
Pediatrics, Pediatric Infectious Diseases
Work:
Children's Hospital
300 Longwood Ave, Boston, MA 02115 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
Education:
New York University (1997)
Therapeutic Uses Of Bpi Protein Products In Bpi-Deficient Humans
US Patent:
6376465, Apr 23, 2002
Filed:
Apr 3, 2000
Appl. No.:
09/541821
Inventors:
Ofer Levy - Boston MA
Assignee:
XOMA Technology Ltd., - Berkeley CA
International Classification:
A61K 3800
US Classification:
514 12, 514 21, 530350, 530324, 435 691
Abstract:
New therapeutic uses for BPI protein products that involve treatment of subjects with a BPI deficiency condition, including selective BPI deficiency, and newborns, including BPI-deficient newborns.
Method For Stimulating The Immune Response Of Newborns
US Patent:
2012012, May 24, 2012
Filed:
Jan 20, 2012
Appl. No.:
13/354487
Inventors:
Ofer Levy - Jamaica Plain MA, US
Michael Wessels - Brookline MA, US
Richard Miller - Maplewood MN, US
Mark Tomai - Woodbury MN, US
Michael Wessels - Brookline MA, US
Richard Miller - Maplewood MN, US
Mark Tomai - Woodbury MN, US
Assignee:
3M INNOVATIVE PROPERTIES COMPANY - Saint Paul MN
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:
A61K 39/39, A61K 39/12, A61K 39/02, A61K 31/4745, A61P 35/00, A61K 45/00, A61P 37/04, A61P 31/04, A61P 31/12, A61K 39/00, A61K 31/7105
US Classification:
4242041, 4241841, 4242341, 4242771, 4242781
Abstract:
The present invention is based on the surprising discovery that agonists of TLR8 are uniquely efficacious in enhancing (e.g. inducing) the immune response of newborns. Thus, agonists of TLR8 serve as both vaccine adjuvants and as adjunctive therapies for acute infection in newborns, preferably the agonist is a TLR8-selective agonist. The immune response induced, or enhanced, in the neonatal host can be, for example, a cytokine immune response and/or a humoral immune response (e.g., antigen-specific).
Method For Stimulating The Immune Response Of Newborns
US Patent:
2008019, Aug 14, 2008
Filed:
Sep 8, 2005
Appl. No.:
11/661746
Inventors:
Ofer Levy - Jamaica Plain MA, US
Michael Wessels - Brookline MA, US
Richard Miller - Maplewood MN, US
Mark Tomai - Woodbury MN, US
Michael Wessels - Brookline MA, US
Richard Miller - Maplewood MN, US
Mark Tomai - Woodbury MN, US
Assignee:
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
3M INNOVATIVE PROPERTIES COMPANY - Saint Paul MN
3M INNOVATIVE PROPERTIES COMPANY - Saint Paul MN
International Classification:
A61K 39/00, A61K 31/437, A61K 31/7105, A61P 31/00
US Classification:
4241841, 514293, 514 44
Abstract:
The present invention is based on the surprising discovery that agonists of TLR8 are uniquely efficacious in enhancing (e.g. inducing) the immune response of newborns. Thus, agonists of TLR8 serve as both vaccine adjuvants and as adjunctive therapies for acute infection in newborns, preferably the agonist is a TLR8-selective agonist. The immune response induced, or enhanced, in the neonatal host can be, for example, a cytokine immune response and/or a humoral immune response (e.g., antigen-specific).
Therapeutic Uses Of Bpi Protein Products In Bpi-Deficient Humans
US Patent:
2006025, Nov 9, 2006
Filed:
May 1, 2006
Appl. No.:
11/415379
Inventors:
Ofer Levy - Boston MA, US
International Classification:
A61K 38/17
US Classification:
514012000
Abstract:
New therapeutic uses for BPI protein products that involve treatment of subjects with a BPI deficiency condition, including selective BPI deficiency, and newborns, including BPI-deficient newborns.
Therapeutic Uses Of Bpi Protein Products In Bpi-Deficient Humans
US Patent:
7041644, May 9, 2006
Filed:
Apr 23, 2002
Appl. No.:
10/128139
Inventors:
Ofer Levy - Boston MA, US
Assignee:
XOMA Technology - Berkeley CA
International Classification:
A61K 38/00
US Classification:
514 12, 514 2
Abstract:
New therapeutic uses for BPI protein products that involve treatment of subjects with a BPI deficiency condition, including selective BPI deficiency, and newborns, including BPI-deficient newborns.
Therapeutic Uses Of Bpi Protein Products In Bpi-Deficient Humans
US Patent:
6153584, Nov 28, 2000
Filed:
Apr 1, 1999
Appl. No.:
9/285124
Inventors:
Ofer Levy - Boston MA
International Classification:
A61K 3800, C07K 100, C07K 1600, C07K 1700, C12P 2106
US Classification:
514 12
Abstract:
New therapeutic uses for BPI protein products that involve treatment of subjects with a BPI deficiency condition, including selective BPI deficiency, and newborns, particularly BPI-deficient newborns.